Nanostics

Nanostics is a developer of diagnostic tests aimed at diagnosing aggressive prostate cancer. The company's technology combines a sensitive extracellular vesicle detection platform with advanced machine learning to diagnose diseases and predict clinically significant prostate cancer through a simple blood test, enabling healthcare professionals to provide patients with clear information about their health through better diagnostics and improved healthcare decision-making.